Literature DB >> 12966594

Preventive medical services among patients with rheumatoid arthritis.

Hilal Maradit Kremers1, Michelle Bidaut-Russell, Christopher G Scott, Megan S Reinalda, Alan R Zinsmeister, Sherine E Gabriel.   

Abstract

OBJECTIVE: To assess the degree to which patients with rheumatoid arthritis (RA) receive health maintenance and preventive care procedures recommended by the United States Preventive Services Task Force (USPSTF), a government appointed independent expert panel whose recommendations are based on a systematic review of the evidence of effectiveness of clinical preventive services.
METHODS: Clinical data from 1987 to 1995 were abstracted from the complete (inpatient and outpatient) medical records of a population based sample of patients with RA (defined using the 1987 American College of Rheumatology diagnostic criteria). We assessed probability of receiving 6 preventive medical services: blood pressure testing (once every 2 years), lipids profile (once every 5 years), flu vaccination (once a year for persons over 65), pneumococcal vaccination (one time for persons over 65), as well as mammograms (biennially for ages 40-49 and annually for those 50 and over) and cervical cancer screening (once every 3 years). These probabilities were summarized using the Kaplan-Meier method. Cox proportional hazards models were used to assess the association of a number of clinical variables with time to performance of each preventive service.
RESULTS: A total of 67 men and 197 women, with a mean age of 64.4 years and median length of followup time of 5.4 years, were identified. In this cohort, the probability of lipids screening by 5 years was 88% and blood pressure screening by 2 years was 95%. Among the 169 patients aged > or = 65 years, the probability of a one-time pneumococcal vaccination was 38% by 5 years of followup and the probability of a yearly flu vaccination was 32%. Among 185 women without a history of breast cancer, mammograms were performed for 68% of women by the end of 2 years from ages 40 to 49 years and for 33% of women by one year beginning at age 50 years. Of the 133 women without a history of hysterectomy, the probability of Papanicolaou smears within 3 years was 77%. No consistent statistically significant association of age, sex, calendar year, total or rheumatologist visits, Charlson comorbidity index, or RA disease characteristics with performance of these preventive services was detected.
CONCLUSION: Patients with RA do not receive optimal health maintenance and preventive care services. Efforts should be made, on the part of all physicians who care for RA patients, to ensure that these effective preventive services are provided.

Entities:  

Mesh:

Year:  2003        PMID: 12966594

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  21 in total

1.  Patterns of preventive health services in rheumatoid arthritis patients compared to a primary care patient population.

Authors:  Androniki Bili; Lisa L Schroeder; Lindsay J Ledwich; H Lester Kirchner; Eric D Newman; Mary Chester M Wasko
Journal:  Rheumatol Int       Date:  2010-03-27       Impact factor: 2.631

Review 2.  The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases.

Authors:  Hilal Maradit Kremers; Elena Myasoedova; Cynthia S Crowson; Guergana Savova; Sherine E Gabriel; Eric L Matteson
Journal:  Rheumatology (Oxford)       Date:  2010-07-13       Impact factor: 7.580

3.  Reasons for failure to receive pneumococcal and influenza vaccinations among immunosuppressed patients with systemic lupus erythematosus.

Authors:  Erica F Lawson; Laura Trupin; Edward H Yelin; Jinoos Yazdany
Journal:  Semin Arthritis Rheum       Date:  2015-01-22       Impact factor: 5.532

4.  No differences in cancer screening rates in patients with rheumatoid arthritis compared to the general population.

Authors:  Seoyoung C Kim; Sebastian Schneeweiss; Jessica A Myers; Jun Liu; Daniel H Solomon
Journal:  Arthritis Rheum       Date:  2012-10

Review 5.  Rheumatoid arthritis and cardiovascular disease.

Authors:  Cynthia S Crowson; Katherine P Liao; John M Davis; Daniel H Solomon; Eric L Matteson; Keith L Knutson; Mark A Hlatky; Sherine E Gabriel
Journal:  Am Heart J       Date:  2013-08-29       Impact factor: 4.749

6.  Suboptimal rates of cervical testing among women with inflammatory bowel disease.

Authors:  Millie D Long; Carol Q Porter; Robert S Sandler; Michael D Kappelman
Journal:  Clin Gastroenterol Hepatol       Date:  2008-10-15       Impact factor: 11.382

Review 7.  Vaccine responses in patients with rheumatoid arthritis.

Authors:  Rajan Ravikumar; Jennifer Anolik; R John Looney
Journal:  Curr Rheumatol Rep       Date:  2007-10       Impact factor: 4.592

8.  Predictors of bone density testing in patients with rheumatoid arthritis.

Authors:  J Aizer; G Reed; A Onofrei; M J Harrison
Journal:  Rheumatol Int       Date:  2008-12-21       Impact factor: 2.631

9.  Mortality trends in rheumatoid arthritis: the role of rheumatoid factor.

Authors:  Angel Gonzalez; Murat Icen; Hilal Maradit Kremers; Cynthia S Crowson; John M Davis; Terry M Therneau; Veronique L Roger; Sherine E Gabriel
Journal:  J Rheumatol       Date:  2008-04-15       Impact factor: 4.666

10.  Comparing guideline-based care quality for inflammatory bowel disease and rheumatoid arthritis patients within a medical home.

Authors:  Freddy Caldera; Sumona Saha; Arnold Wald; David M Cooley; Ying-Qi Zhao; Zhanhai Li; Christie M Bartels
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2016-04-12       Impact factor: 3.869

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.